Form 8-K - Current report:
SEC Accession No. 0001493152-25-000294
Filing Date
2025-01-03
Accepted
2025-01-03 17:20:20
Documents
17
Period of Report
2024-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49708
2 ex4-1.htm EX-4.1 115551
3 ex10-1.htm EX-10.1 228736
4 ex10-2.htm EX-10.2 187254
  Complete submission text file 0001493152-25-000294.txt   909475

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE celu-20241227.xsd EX-101.SCH 3892
6 XBRL DEFINITION FILE celu-20241227_def.xml EX-101.DEF 30206
7 XBRL LABEL FILE celu-20241227_lab.xml EX-101.LAB 37063
8 XBRL PRESENTATION FILE celu-20241227_pre.xml EX-101.PRE 27229
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6104
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 25507898
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)